Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for End of Cycle Inspection and Documentation for Lyophilization

Posted on By

SOP for End of Cycle Inspection and Documentation for Lyophilization

Standard Operating Procedure for End of Cycle Inspection and Documentation for Lyophilization

1) Purpose

This SOP outlines the steps for inspecting the product and equipment after the lyophilization cycle is complete, and the proper documentation procedures to ensure quality and regulatory compliance.

2) Scope

This SOP applies to all operators and QA personnel involved in the inspection of lyophilized products and equipment at the end of the freeze-drying cycle.

3) Responsibilities

  • Operators: Responsible for performing the inspection and documenting any deviations or issues observed during or after the cycle.
  • QA Personnel: Responsible for reviewing the inspection reports and ensuring that all records are complete and accurate.
See also  SOP for Formulating Lyophilized Cancer Therapeutics

4) Procedure

4.1 Visual Inspection of Product

4.1.1 Appearance of Vials

  • 4.1.1.1 Inspect each vial for signs of collapse, discoloration, or any other defects that may have occurred during the freeze-drying process.
  • 4.1.1.2 Record the number of defective vials and note any patterns or abnormalities in the defects.

4.1.2 Sealing and Closure

  • 4.1.2.1 Ensure that all vials have been properly sealed with their rubber stoppers fully seated and crimped, ensuring no leaks.

4.2 Equipment Inspection

4.2.1 Chamber Inspection

  • 4.2.1.1 Inspect the lyophilizer chamber for any residual product, frost buildup, or contamination. Clean as necessary before the next cycle.

4.2.2 Sensor and

Instrument Calibration Check
  • 4.2.2.1 Verify that all sensors (temperature, vacuum) performed within the specified range during the cycle. Record any deviations in performance.

4.3 Documentation

Complete the End of Cycle Inspection Logbook, documenting the condition of the product and equipment. Ensure that any defects or issues are addressed and signed off by both the operator and QA personnel before the release of the batch.

5) Abbreviations

  • QA: Quality Assurance

6) Documents

  • End of Cycle Inspection Logbook

7) References

  • Pharmacopoeial guidelines for lyophilization equipment and product inspection

8) SOP Version

Version 1.0

Annexure

End of Cycle Inspection Logbook Template

Date Product Name Batch No. Inspection Findings Number of Defective Vials Operator Initials QA Verification
DD/MM/YYYY Product Name Batch Number Details of Findings Number Operator Name QA Initials
           


Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: SOP for Operation and Maintenance of HVAC Systems
Next Post: SOP for Risk Assessment of Nanoparticle Manufacturing Processes

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version